Sixteen Chinese COVID-19 vaccines undergoing clinical trials for national, global supply

As the demand for the COVID-19 vaccine intensified around the world, China said that it has increased the number of vaccines undergoing clinical trials to 16 from 11 to step up supplies at home and abroad. China is conducting clinical trials of 16 COVID-19 vaccines, seven of which have entered phase-III trials and one has conditionally hit the market, Wu Yuanbin, an official with the Ministry of Science and Technology, was quoted as saying by the state-run CGTN TV.

Wu made the comments during a haematology conference on Saturday.

Yang Sheng, Deputy Director of China's National Medical Products Administration's drug registration bureau, said last month that a total of 11 Chinese vaccine candidates are in different stages of testing at home and abroad.

Currently, China is vaccinating people at home and some countries abroad with two vaccines. The Chinese government has given conditional approval to Sinopharm while the results of the phase-3 trial is yet to be released.

The World Health Organisation (WHO) is reviewing the trials of both the vaccines.

China has said that so far 46 countries have expressed their desire to import the China-made vaccines.

Respiratory-disease expert Zhong Nanshan said on Sunday that the mass inoculation of homegrown COVID-19 vaccines underway in China shows the vaccines are safe and effective.

The two vaccines currently in use in China – the China National Biotec Group (CNBG) COVID-19 vaccine and the CoronaVac vaccine developed by China's Sinovac Biotech Ltd – are both inactivated vaccines that are relatively safe, Zhong said at the launch ceremony of an event in south China's Guangdong province.

According to the Chinese Centre for Disease Control and Prevention (China CDC), more than 24 million doses of the COVID-19 vaccine had been administered in China till Sunday, state-run Xinhua news agency reported.

"The rate of the vaccines' mild adverse reactions, which include fever, soar arms and other symptoms, is six per 100,000 people," Zhong said.

The rate of severe adverse vaccine reactions is one in a million, only one third of that of flu vaccines, he said.



from Firstpost Tech Latest News https://ift.tt/3pB5gut

Comments

Post a Comment

Popular posts from this blog

Elon Musk’s bid spotlights Twitter’s unique role in public discourse – and what changes might be in store

Twitter has been in the news a lot lately, albeit for the wrong reasons. Its stock growth has languished and the platform itself has largely remained the same since its founding in 2006. On April 14, 2022, Elon Musk, the world’s richest person, made an offer to buy Twitter and take the public company private. In a filing with the Securities and Exchange Commission , Musk stated, “I invested in Twitter as I believe in its potential to be the platform for free speech around the globe, and I believe free speech is a societal imperative for a functioning democracy.” As a researcher of social media platforms , I find that Musk’s potential ownership of Twitter and his stated reasons for buying the company raise important issues. Those issues stem from the nature of the social media platform and what sets it apart from others. What makes Twitter unique Twitter occupies a unique niche. Its short chunks of text and threading foster real-time conversations among thousands of people, which
Read more

To reach net-zero emissions and remove CO2 from the air, scientists drawn up six priorities

Image
To reach net-zero emissions by 2050, global emissions must be cut faster and deeper than the world has yet managed. But even then, some hard-to-treat sources of pollution – in aviation, agriculture and cement making – may linger for longer than we would like. It will take time for clean alternatives to arrive and replace them. That means the world also needs to find and ramp up ways of taking CO₂ out of the atmosphere to stabilise the climate. Just meeting the UK’s net-zero target is likely to require the removal of 100 million tonnes of CO₂ a year , similar in size to current emissions from the country’s largest-emitting sector, road transport, but in reverse. The UK government’s announcement of £31.5 million (US$44.7 million) in support for research and development of carbon removal is welcome. And while trials of new tech will help, there are many social issues that need to be tackled if removing greenhouse gases is to succeed. Done right, carbon removal could be the perfect a
Read more

NASA is planning to partner with SpaceX to reboost the Hubble Telescope and extend its life

Image
The Hubble Space Telescope is one of the most important scientific achievements of the human species that has helped us understand space. It has been in orbit for over 30 years and has been feeding some of the most vital streams of information that has not only helped us steer our space exploration efforts, but also solve some of the more deep mysteries of the universe . NASA would love to extend its usable life for as long as possible. Unfortunately, for some years now, Hubble Space Telescope has been slipping out of its orbit. That is why, NASA is planning to team up with Elon Musk’s SpaceX and place it into a higher much more stable orbit. NASA, SpaceX and Jared Isaacman, a private astronaut with the Polaris Program, hosted a media teleconference on Thursday to announce a feasibility study that will look into sending a commercial Dragon spacecraft to reboost the Hubble Space Telescope . This will, in effect place the telescope into a higher and more stable orbit than it’s curren
Read more